321
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that
has challenged patients, their families, and the medical community for generations.
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More
report
Corporate Philanthropy: Emerging Strategies for Lasting Impact
Corporate philanthropy is in transition. External trends and heightened stakeholder expectations ha
ve placed new pressures on the corporate sector.
+ Read More
report
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program
The Kissick Family Foundation, with guidance from MI Philanthropy’s Science and Health team, is rel
easing its first Request for Proposals (RFP) to fund research that accelerates basic and fundamental discoveries for sporadic FTD.
+ Read More
report
Frontotemporal Dementia: A Giving Smarter Guide
Frontotemporal dementia (FTD) refers to a family of neurodegenerative conditions that cause changes
in behavior, mood, executive function, language, memory, and motor function.
+ Read More
panel
Part 1: Authentic Leadership
panel
Part 2: Impact and Progress
panel